Patient Group Directives (PGDs)

A Patient Group Direction allows specified healthcare professionals to supply and or administer a medicine directly to a patient with an identified clinical condition without him/her necessarily seeing a prescriber. Patients may present directly to healthcare professionals using PGDs in their services without seeing a doctor. Alternatively the patient may have been referred by a doctor to another service. Whichever way the patient presents, the healthcare professional working within the PGD is responsible for assessing that the patient fits the criteria set out in the PGD.

Emergency Hormonal Contraception (EHC):
PGD for the administration of Levonorgestrel 1500micrograms (review date Oct 2023)
PGD for the supply of Desogestrel Progestogen-only Contraceptive Pill (POP) (review date Nov 2023)
PGD for the supply of Ulipristal Acetate Emergency Contraception (UPA-EC) (review date Oct 23)

Immunisation Service:
PGD for the administration of Human Papilloma Virus (HPV) Vaccine (review date Sept 2021)
PGD for the administration of Meningococcal ACWY Vaccine (review date Oct 2021)
PGD for the administration of MMR Vaccine (review date Sept 2021)
PGD for the administration of Diphtheria, Tetanus and Poliomyelitis (inactivated) Vaccine (review date Mar 2019)
PGD for the administration of Inactivated Influenza Vaccine (review date 31 July 2023)

Pharmacy First:
PGD for the supply of Aciclovir tabs/dispersible tabs (review date Apr 23)
PGD for the supply of Flucloxacillin caps/oral sol (review date May 23)
PGD for the supply of Fusidic Acid cream (review date Aug 24)
PGD for the supply of Nitrofurantoin MR caps (review date Aug 24)
PGD for the supply of Trimethoprim tabs (review date Aug 24)